Navigation Links
Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
Date:3/31/2008

The Company's cardiovascular medicine clinical trial program includes ONTARGET, PRoFESS, TRANSCEND and other studies involving more than 75,000 patients in more than 40 countries. These studies were designed to evaluate ways to reduce the risk of damaging events in the heart, brain and other organs due to cardiovascular disease and to uncover new treatment strategies that improve patient outcomes and care.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2006, Boehringer Ingelheim posted net sales of US $13.3 billion (10.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com .

About Micardis(R) (telmisartan)

Telmisartan is marketed in the United States by Boehringer Ingelheim as MICARDIS(R) tablets. MICARDIS is indicated for the treatment of hypertension.

USE IN PREGNANCY

When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, MICARDIS tablets should be discontinued as soon as possible (see WARNINGS,
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
2. Viatronix V3D-Colon Utilized in Another Landmark Study
3. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
4. Hospital Launches Landmark Emergency Medicine Project
5. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
6. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... and MELVILLE, N.Y. , ... CAH ), one of the world,s largest health ... HSIC ), the world,s largest provider of health ... and medical practitioners, today announced that the companies have ... of the most comprehensive service and product offerings to ...
(Date:11/21/2014)... LAVAL, QC , Nov. 20, 2014 /CNW Telbec/ ... pleased to announce the following appointments: ... leadership team in the newly created role of Chief ... a BioPhotonic system using topical photoconverter gel for the ... as surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... HILLS, Calif. , Nov. 20, 2014 Oxis ... Ken Eaton , the election of Anthony J. Cataldo ... as President. Effective November 19, 2014, Ken ... member of the Board of Directors of Oxis International, Inc. ... Cataldo has been named Chief Executive Officer of Oxis ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
... of endoscopic ablation therapy using the HALO System ... controlled trialSUNNYVALE, Calif., May 27 Results from ... New England Journal of Medicine reveal that ... Inc.) is highly effective for complete eradication of ...
... the,presentation of data with PROSTVAC(TM) - a promising, late-stage vaccine,candidate ... hosting a Q&A session at the ASCO Annual Meeting. , ... 09 AM EDT to 10 AM EDT. , ... Florida,32819 , At the Q&A session, ...
Cached Medicine Technology:Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development 2Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development 3
(Date:11/23/2014)... 23, 2014 More than two dozen ... a federal litigation involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), ... Liebhard LLP reports. , A Case List updated ... class of Type 2 diabetes medications referred to as ... District Court, Southern District of California, where a federal ...
(Date:11/23/2014)... Church, VA (PRWEB) November 23, 2014 ... TV Have in Common, **FDAnews On-Demand Webinar**, Dec. 11, ... http://www.fdanews.com/TheFDAisWatchingOnDemand , The FDA’s focus on promotional activities ... , Now they're looking at websites, Twitter, ... Mark the calendar for Thursday, Dec. 11, for On-Demand ...
(Date:11/23/2014)... City, Utah (PRWEB) November 23, 2014 ... health insurance reimbursement for small businesses, announced their ... book, The End of Employer-Provided Health Insurance. ... insurance is the greatest financial risk facing most ... facing U.S. employers, small and large, when it ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 PrettyTailor ... website with a new big promotion. Customers can buy ... detailed information, customers can visit its website. , As ... apparel and occasion dresses. It mainly provides four types ... bride dresses and flower girl dresses. It also provides ...
(Date:11/22/2014)... November 23, 2014 BambooFlooringChina.com is ... company has proudly released its new collection of bamboo ... rates, up to 29% off. , According to ... sturdy tree-like grass, making it a highly renewable resource. Their ... have a mixing color which comes from natural bamboo with ...
Breaking Medicine News(10 mins):Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2
... 2007 - From Microscope to Stethoscope, the distinguished public ... McGill University Health Centre (MUHC), is embarking on its ... Vassilios Papadopoulos, Director of the Research Institute of the ... research may bring to patients suffering from Alzheimers disease. ...
... Oct. 2 LifeMasters Supported SelfCare,Inc., a leading ... services, today announced the appointment of Charles A. ... client experience.,Dr. Peck will be responsible for working ... disease management offerings, as well,as creating a client ...
... Efficiently Providing ... Choices, WALTHAM, Mass., Oct. 2 CaseNET, Inc., ... today,that Fallon Community Health Plan (FCHP) successfully deployed the ... "We were looking for a vendor with a true ...
... (October 1, 2007) Colorectal cancer is one of ... the United States. The American Gastroenterological Association (AGA) Institute ... patients who are screened for the disease. , ... on September 28, researchers presented results from the National ...
... Dijuana Lewis Promoted to Executive Leadership Positions, Brad Fluegel Named ... ... Company, INDIANAPOLIS, Oct. 2 Angela Braly, president,and CEO ... that will strengthen the company,s ability to focus on and ...
... 2 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... Hart-Scott-Rodino Antitrust Improvements Act for its,collaboration with Ortho-McNeil, ... on September 13, 2007. As part of ... and commercialization rights to two of its diabetes,drugs, ...
Cached Medicine News:Health News:Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience 2Health News:Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience 3Health News:Fallon Community Health Plan Selects CaseNET to Enhance Care Services Infrastructure 2Health News:Fallon Community Health Plan Selects CaseNET to Enhance Care Services Infrastructure 3Health News:Virtual colonoscopy -- a new technology for colorectal cancer screening? 2Health News:WellPoint Announces Realignment of Core Businesses; Names New Executives 2Health News:WellPoint Announces Realignment of Core Businesses; Names New Executives 3Health News:WellPoint Announces Realignment of Core Businesses; Names New Executives 4Health News:WellPoint Announces Realignment of Core Businesses; Names New Executives 5Health News:WellPoint Announces Realignment of Core Businesses; Names New Executives 6Health News:Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc. 2
... The Sysmex UF-100 is designed to ... microscopic analysis. It combines the superior ... automated urine sample analysis. Continuous sampling ... the rack-based autosamplers, streamlining sample processing in ...
... been designed as a compact, cost-effective and ... private clinics or as a second system. ... most commonly required investigations such as Uroflowmetry, ... Add-on options are available for Urethral Pressure ...
... Delphis™ is ideal for any ... approach to performing a UDS procedure. ... with the options of a Pocket ... Laptop. Delphis with Bluetooth™ wireless technology ...
... TRITON™ offers ultimate flexibility by allowing you ... printer and display. Wall-mount anywhere in the ... choosing a laptop, touch screen tablet, industrial ... technology, this multi-function patient tower provides more ...
Medicine Products: